Ergoteles LLC Cytokinetics Inc Transaction History

Ergoteles LLC

  • $68.2 Billion
  • Q3 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 10, 2023
SELL
$33.36 - $45.71 $801,173 - $1.1 Million
-24,016 Reduced 68.55%
11,020 $387,000
Q4 2022

Feb 14, 2023
BUY
$35.77 - $51.11 $1.25 Million - $1.79 Million
35,036 New
35,036 $1.61 Million
Q1 2022

May 13, 2022
SELL
$29.74 - $46.0 $1.42 Million - $2.2 Million
-47,841 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$34.35 - $46.38 $1.64 Million - $2.22 Million
47,841 New
47,841 $2.18 Million

Others Institutions Holding CYTK

# of Institutions
410
Shares Held
125M
Call Options Held
4.6M
Put Options Held
2.43M
View Full List

About CYTOKINETICS INC

CYTK Quotes by TradingView
  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $4.62B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Ergoteles LLC Portfolio

Follow Ergoteles LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ergoteles LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email